Hospira Sued Over Infusion Patent, Sale Contract
Braun claims that several of Hospira's so-called infusion management systems infringe its newly purchased U.S. Patent 7,933,780, titled “Method and apparatus for controlling an infusion pump or the like.”
The accused products include several devices in Hospira's infusion management line of products, part of a business division that earns the company about $1 billion a...
Already a subscriber? Click here to login